The short version
8 companies supply this market — a reasonable cushion if one runs into trouble.
Market view
ritonavir · Powder
12 marketed package NDCs · 8 active manufacturers
Most dispensed: 100 mg · Tablet, Film Coated · #30 tablet, film coateds/bottle · 100 mg · Tablet, Film Coated · #30 blister packs/box, unit-dose / 1 tablet, film coated in 1 blister pack · 100 mg · Tablet · #30 tablets/bottle
What changed in the last 90 days
Every detected change for ritonavir, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- RitonavirAug 19, 2026Price downNADAC $0.62712 → $0.60668 per unit (-3.26%)
- RitonavirAug 19, 2026Price downNADAC $0.62712 → $0.60668 per unit (-3.26%)
- RitonavirAug 19, 2026Price downNADAC $0.62712 → $0.60668 per unit (-3.26%)
- NorvirAug 19, 2026Price downNADAC $8.33904 → $8.32808 per unit (-0.13%)
- NorvirJul 25, 2026New shortageby this manufacturerAbbVie Inc.'s Norvir (Tablet, 100 mg) is newly in shortage14 companies market norvir
- NorvirJul 25, 2026New shortageby this manufacturerAbbVie Inc.'s Norvir (Oral Powder, 100 mg) is newly in shortage14 companies market norvir
- NorvirJul 22, 2026Price upNADAC $8.33667 → $8.33904 per unit (+0.03%)
- RitonavirJul 22, 2026Price downNADAC $0.6618 → $0.62712 per unit (-5.24%)
- RitonavirJul 22, 2026Price downNADAC $0.6618 → $0.62712 per unit (-5.24%)
- RitonavirJul 22, 2026Price downNADAC $0.6618 → $0.62712 per unit (-5.24%)
Same drug class
Other molecules FDA puts in Cytochrome P450 3A Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- atazanavir and cobicistat· 1 maker
- elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide· 1 maker
- ritonavir 100 mg· 1 maker
- darunavir, cobicistat, emtricitabine, and tenofovir alafenamide· 2 makers
- elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate· 2 makers
- darunavir ethanolate and cobicistat· 3 makers
- cobicistat· 4 makers
- lopinavir and ritonavir· 5 makers
Common questions
- Is Ritonavir in shortage right now?
- No. FDA does not currently list Ritonavir in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Ritonavir?
- 14 companies have marketed Ritonavir in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Ritonavir cost?
- The typical pharmacy pays about $0.6067 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
Shortage reports for this molecule
- Planned discontinuation — Norvir, Oral Powder, 100 mg (NDC 0074-3399-30)Jul 24, 2026
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.